Skip to content

Dogwood Therapeutics DWTX Book value per share

Book value per share at other companies

Eli Lilly logo
Eli LillyLLY
$34.82+98.9%
Pfizer logo
PfizerPFE
$15.72-0.6%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$75.54+18.8%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$7.80+9.2%
Bioventus logo
BioventusBVS
$2.70+20.2%
Avanos Medical logo
Avanos MedicalAVNS
$16.47-8.2%

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Calculated from Dogwood Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's book value per share?
Dogwood Therapeutics (DWTX) reported book value per share of $2.40 in Q1 2026.
How has Dogwood Therapeutics's book value per share changed year-over-year?
Dogwood Therapeutics's book value per share decreased by 51.1% year-over-year, from $4.92 to $2.40.
What is the long-term trend for Dogwood Therapeutics's book value per share?
Over 5 years (2020 to 2025), Dogwood Therapeutics's book value per share has grown at a 19.9% compound annual growth rate (CAGR), from $6.08 to $15.05.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.